MEDI-5771

N/A

Report date: 2025/01/26 16:56:36

Base Information

Drug NameMEDI-5771

Drug Alias NamePD-1/GITRL bispecific fusion protein (Medimmune)dual PD-1 checkpoint inhibitor/GITR costimulator (Medimmune)MEDI-5771

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed cell death protein 1 blockersGlucocorticoid-induced tumor necrosis factor receptor-related protein agonists

TargetsProgrammed cell death protein 1Glucocorticoid-induced tumor necrosis factor receptor-related protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A